These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8658174)

  • 81. Presenting plasma HIV RNA level and rate of CD4 T-cell decline.
    Gottlieb GS; Hawes SE; Nickle DC; Herbeck JT; Kiviat NB; Mullins JI; Sow PS
    JAMA; 2007 Feb; 297(8):805; author reply 806-7. PubMed ID: 17327518
    [No Abstract]   [Full Text] [Related]  

  • 82. The persistence of (HIV in) memory (T cells).
    Coen DM
    Trends Microbiol; 1998 Apr; 6(4):129-30. PubMed ID: 9587186
    [No Abstract]   [Full Text] [Related]  

  • 83. Cytotoxic T lymphocytes in HIV-1 infection: a killing paradox?
    Klein MR; van der Burg SH; Pontesilli O; Miedema F
    Immunol Today; 1998 Jul; 19(7):317-24. PubMed ID: 9666605
    [No Abstract]   [Full Text] [Related]  

  • 84. Hide, shield and strike back: how HIV-infected cells avoid immune eradication.
    Peterlin BM; Trono D
    Nat Rev Immunol; 2003 Feb; 3(2):97-107. PubMed ID: 12563294
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Regulation of CD8+ T-cell cytotoxicity in HIV-1 infection.
    Saeidi A; Buggert M; Che KF; Kong YY; Velu V; Larsson M; Shankar EM
    Cell Immunol; 2015; 298(1-2):126-33. PubMed ID: 26520669
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Viral latency in HIV disease.
    McCune JM
    Cell; 1995 Jul; 82(2):183-8. PubMed ID: 7628009
    [No Abstract]   [Full Text] [Related]  

  • 87. What do mathematical models tell us about killing rates during HIV-1 infection?
    Gadhamsetty S; Beltman JB; de Boer RJ
    Immunol Lett; 2015 Nov; 168(1):1-6. PubMed ID: 26279491
    [TBL] [Abstract][Full Text] [Related]  

  • 88. AIDS pathogenesis: a finite immune response to blame?
    Miedema F; Klein MR
    Science; 1996 Apr; 272(5261):505-6. PubMed ID: 8614796
    [No Abstract]   [Full Text] [Related]  

  • 89. Resistance of HIV-infected cells to cytotoxic T lymphocytes.
    Collins KL
    Microbes Infect; 2004 Apr; 6(5):494-500. PubMed ID: 15109965
    [TBL] [Abstract][Full Text] [Related]  

  • 90. CD8 lymphocytes in HIV infection: helpful and harmful.
    Famularo G; Moretti S; Marcellini S; Nucera E; De Simone C
    J Clin Lab Immunol; 1997; 49(1):15-32. PubMed ID: 9819670
    [TBL] [Abstract][Full Text] [Related]  

  • 91. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
    Yang OO
    Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
    [No Abstract]   [Full Text] [Related]  

  • 92. Defying death--HIV mutation to evade cytotoxic T lymphocytes.
    Lieberman J
    N Engl J Med; 2002 Oct; 347(15):1203-4. PubMed ID: 12374884
    [No Abstract]   [Full Text] [Related]  

  • 93. Pediatric HIV infection: immune and viral evaluation.
    Rodriguez CA; Lujan-Zilbermann J; Emmanuel PJ
    Fetal Pediatr Pathol; 2006; 25(5):261-75. PubMed ID: 17438666
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Rate of killing of HIV-infected T cells and disease progression.
    Huynen MA; Neumann AU
    Science; 1996 Jun; 272(5270):1962. PubMed ID: 8658174
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.